The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Nts45 Regulatory News (33JE)

Share Price Information for Barclays Nts45 (33JE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 284.95034
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 284.95034
33JE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Supplement

28 Jul 2023 18:05

RNS Number : 6238H
Barclays Bank PLC
28 July 2023
 

Publication of Supplement

The following supplement has been approved by the Financial Conduct Authority and the International Securities Market and is available for viewing:

Supplement 1 dated 28 July 2023 (the "Supplement") to the FCA Registration Document dated 6 March 2023 for the Barclays Bank PLC (the "Registration Document").

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6238H_1-2023-7-28.pdf

A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Barclays Treasury

1 Churchill Place

Canary Wharf

London E14 5HP

 

DISCLAIMER - INTENDED ADDRESSEES

IMPORTANT: You must read the following before continuing: The following applies to the Supplement available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Supplement. In accessing the Supplement, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

NEITHER THE SUPPLEMENT NOR THE REGISTRATION DOCUMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE SUPPLEMENT AND/OR THE REGISTRATION DOCUMENT MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE SUPPLEMENT AND/OR THE REGISTRATION DOCUMENT IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

NOTHING IN THIS ELECTRONIC PUBLICATION OR IN THE SUPPLEMENT OR THE REGISTRATION DOCUMENT CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION. THE NOTES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION.

Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (as specified in the Registration Document) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom any offer of Notes is not addressed. Prior to relying on the information contained in the Supplement and/or the Registration Document you must ascertain whether or not you are part of the intended addressees of the information contained therein.

Confirmation of your Representation: In order to be eligible to view the Supplement and/or the Registration Document or make an investment decision with respect to the Notes, you must be a person other than a U.S. person (within the meaning of Regulation S under the Securities Act). By accessing the Supplement and/or the Registration Document, you shall be deemed to have represented that you and any customers you represent are not U.S. persons (as defined in Regulation S to the Securities Act), and that you consent to delivery of the Supplement and any supplements thereto via electronic publication.

You are reminded that the Supplement has been made available to you on the basis that you are a person into whose possession the Supplement and/or the Registration Document may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver the Supplement and/or the Registration Document to any other person.

The Supplement and/or the Registration Document does not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of the issuer in such jurisdiction. Under no circumstances shall the Supplement and/or the Registration Document constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Notes issued or to be issued pursuant to the Supplement and/or the Registration Document, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Supplement has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the issuer, its advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Supplement made available to you in electronic format and the hard copy version available to you on request from the issuer.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPNKFBKABKDPOB
Date   Source Headline
25th Apr 20247:00 amRNSPublication of Pillar 3 report Q1 2024
12th Apr 20243:13 pmRNSApproval of Barclays Bank PLC PSL Base Prospectus
6th Mar 20243:51 pmRNSPublication of Final Terms
21st Feb 20246:23 pmRNSAnnual Financial Report on Form 20-F
20th Feb 20247:00 amRNSAnnual Financial Report
15th Feb 20242:00 pmRNSPublication of Final Terms
10th Jan 20249:32 amRNSPublication of Final Terms
3rd Jan 202411:52 amRNSPublication of Final Terms
21st Dec 20233:02 pmRNSPublication of Final Terms
7th Dec 20232:50 pmRNSPublication of Final Terms
24th Oct 20237:01 amRNSQ3 2023 Pillar 3 report
23rd Oct 20233:47 pmRNSHolding(s) in Company
13th Oct 20232:00 pmRNSNotice of redemption of debt securities
12th Oct 202310:37 amRNSDecision Notice issued by RDC regarding former CEO
14th Aug 20231:45 pmRNSRedemption Notice
31st Jul 20233:30 pmRNSPublication of Suppl.Prospcts
28th Jul 20236:05 pmRNSPublication of Supplement
27th Jul 20237:00 amRNSHalf-year Report
14th Jul 202311:40 amRNSNotice of redemption of debt securities
21st Jun 20232:40 pmRNSPublication of Final Terms
19th Jun 20234:00 pmRNSPublication of a Prospectus
15th Jun 20232:21 pmRNSStabilisation Notice
9th Jun 20231:00 pmRNSNotice of redemption of debt securities
8th Jun 20231:52 pmRNSNotice of intention to redeem debt securities
22nd May 202310:18 amRNSHolding(s) in Company
17th May 20237:00 amRNSResults of placing in London Stock Exchange Group
16th May 20234:40 pmRNSProposed placing in London Stock Exchange Group
27th Apr 20237:30 amRNSPublication of Pillar 3 report (Q1 2023)
21st Apr 20234:00 pmRNSHolding(s) in Company
17th Apr 202312:32 pmRNSPublication of UK BP dated 17 April 2023
14th Apr 20235:21 pmRNSPublication of 2023 Preference Share Linked BP
5th Apr 202311:35 amRNSHolding(s) in Company
3rd Apr 202310:30 amRNSHolding(s) in Company
28th Mar 20233:14 pmRNSHolding(s) in Company
21st Mar 20236:06 pmRNSHolding(s) in Company
21st Mar 20233:54 pmRNSHolding(s) in Company
20th Mar 20235:27 pmRNSHolding(s) in Company
14th Mar 202311:27 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSResults of placing in Alfa Financial
8th Mar 20234:59 pmRNSProposed placing in Alfa Financial
3rd Mar 20231:00 pmRNSFurther update re Chief Executive Officer
21st Feb 202311:08 amRNSHolding(s) in Company
16th Feb 202311:45 amRNSAnnual Report on Form 20-F
15th Feb 20237:00 amRNSAnnual Financial Report
9th Feb 20234:14 pmRNSHolding(s) in Company
31st Jan 20236:04 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSDirectorate Change
19th Jan 20235:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.